Petr Chlapek

491 total citations
17 papers, 350 citations indexed

About

Petr Chlapek is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Petr Chlapek has authored 17 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Petr Chlapek's work include Retinoids in leukemia and cellular processes (7 papers), Neuroblastoma Research and Treatments (4 papers) and Cancer therapeutics and mechanisms (3 papers). Petr Chlapek is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), Neuroblastoma Research and Treatments (4 papers) and Cancer therapeutics and mechanisms (3 papers). Petr Chlapek collaborates with scholars based in Czechia, Australia and Portugal. Petr Chlapek's co-authors include Renata Veselská, Jaroslav Štěrba, Pavel Mazánek, Jakub Neradil, J. Škoda, Karel Zitterbart, Markéta Hermanová, Iva Staniczková Zambo, Karel Veselý and Tomáš Loja and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Petr Chlapek

17 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petr Chlapek Czechia 10 224 146 68 59 48 17 350
Giorgia Foggetti Italy 11 235 1.0× 183 1.3× 71 1.0× 103 1.7× 19 0.4× 18 365
Manuela Hugle Germany 11 263 1.2× 107 0.7× 56 0.8× 41 0.7× 25 0.5× 14 365
Karen M. Hite United States 9 239 1.1× 156 1.1× 51 0.8× 138 2.3× 12 0.3× 10 366
Janet Mendonca United States 9 379 1.7× 155 1.1× 109 1.6× 85 1.4× 10 0.2× 13 510
Mary Rose Pambid United States 8 225 1.0× 86 0.6× 40 0.6× 78 1.3× 12 0.3× 12 353
Chu Myong Seong South Korea 12 360 1.6× 133 0.9× 50 0.7× 51 0.9× 10 0.2× 30 511
Shi Xu China 11 204 0.9× 113 0.8× 50 0.7× 121 2.1× 12 0.3× 19 411
Sabine Häcker Germany 10 438 2.0× 111 0.8× 30 0.4× 100 1.7× 39 0.8× 12 548
Anqun Tang China 5 243 1.1× 143 1.0× 43 0.6× 50 0.8× 21 0.4× 6 361

Countries citing papers authored by Petr Chlapek

Since Specialization
Citations

This map shows the geographic impact of Petr Chlapek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Chlapek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Chlapek more than expected).

Fields of papers citing papers by Petr Chlapek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Chlapek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Chlapek. The network helps show where Petr Chlapek may publish in the future.

Co-authorship network of co-authors of Petr Chlapek

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Chlapek. A scholar is included among the top collaborators of Petr Chlapek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Chlapek. Petr Chlapek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chlapek, Petr, et al.. (2022). Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors. International Journal of Molecular Sciences. 23(15). 8549–8549. 3 indexed citations
2.
3.
Škoda, J., Jakub Neradil, Petr Chlapek, et al.. (2020). Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms. Cancers. 12(12). 3781–3781. 8 indexed citations
4.
Škoda, J., et al.. (2020). Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration. International Journal of Molecular Sciences. 21(9). 3157–3157. 43 indexed citations
5.
Veselská, Renata, Marta Ježová, Michal Kýr, et al.. (2019). Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy. Frontiers in Oncology. 9. 1221–1221. 7 indexed citations
6.
Gomes, Sara, Liliana Raimundo, Joana Soares, et al.. (2019). New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma. Cancer Letters. 446. 90–102. 34 indexed citations
7.
Chlapek, Petr, et al.. (2019). Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers. PLoS ONE. 14(6). e0218269–e0218269. 10 indexed citations
8.
9.
Chlapek, Petr, et al.. (2018). Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids. International Journal of Molecular Sciences. 19(1). 132–132. 51 indexed citations
10.
Chlapek, Petr, et al.. (2017). Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups. PLoS ONE. 12(2). e0172552–e0172552. 4 indexed citations
11.
Krzyžanková, Miroslava, Petr Chlapek, Jakub Neradil, et al.. (2014). LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines. Tumor Biology. 35(8). 7617–7627. 6 indexed citations
12.
Chlapek, Petr, Jakub Neradil, Martina Rédová, et al.. (2014). The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression. Cancer Cell International. 14(1). 51–51. 10 indexed citations
13.
Veselská, Renata, Petr Chlapek, Miroslava Krzyžanková, et al.. (2014). The power of natural phenolic compounds: caffeic acid is able to enhance the retinoid-induced differentiation of tumor cells. Cancer & Metabolism. 2(S1). 1 indexed citations
14.
Šáňa, Jiří, Iva Staniczková Zambo, J. Škoda, et al.. (2011). CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines. Analytical Cellular Pathology. 34(6). 303–318. 26 indexed citations
15.
Šáňa, Jiří, Iva Staniczková Zambo, J. Škoda, et al.. (2011). CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.. SHILAP Revista de lepidopterología. 34(6). 303–18. 27 indexed citations
16.
Chlapek, Petr, Martina Rédová, Karel Zitterbart, et al.. (2010). Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study. Journal of Experimental & Clinical Cancer Research. 29(1). 45–45. 13 indexed citations
17.
Veselská, Renata, Markéta Hermanová, Tomáš Loja, et al.. (2008). Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer. 8(1). 300–300. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgia Foggetti Breakdown of academic impact, for papers by Manuela Hugle Breakdown of academic impact, for papers by Karen M. Hite Breakdown of academic impact, for papers by Janet Mendonca Breakdown of academic impact, for papers by Mary Rose Pambid Breakdown of academic impact, for papers by Chu Myong Seong Breakdown of academic impact, for papers by Shi Xu Breakdown of academic impact, for papers by Sabine Häcker Breakdown of academic impact, for papers by Anqun Tang
Rankless by CCL
2026